Stay updated on Effect of Farxiga in Hyperfiltration: Renal Clinical Trial
Sign up to get notified when there's something new on the Effect of Farxiga in Hyperfiltration: Renal Clinical Trial page.

Latest updates to the Effect of Farxiga in Hyperfiltration: Renal Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; the prior funding/operating-status notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the revision note updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated metadata labels, including the 'Last Update Submitted that Met QC Criteria' text, the 'No FEAR Act Data' label, and the revision tag updated to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section with Texas as a location; removed the Texas Locations header and the HHS Vulnerability Disclosure link, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision information updated from v3.2.0 to v3.3.2 is visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Effect of Farxiga in Hyperfiltration: Renal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Farxiga in Hyperfiltration: Renal Clinical Trial page.